POLYSENSITIVITY TO ANTI-LEPROSY DRUGS.
D003622:Dapsone; D003875:Drug Eruptions; D004342:Drug Hypersensitivity; D004351:Drug Resistance; D004352:Drug Resistance, Microbial; D006801:Humans; D007918:Leprosy; D009549:Nigeria; D000077145:Sulfanilamide; D013424:Sulfanilamides; D013432:Sulfathiazoles; D013449:Sulfonamides; D013450:Sulfones; D014116:Toxicology
D013424:Sulfanilamides; D013432:Sulfathiazoles; D013449:Sulfonamides; D013450:Sulfones; D000077145:Sulfanilamide; D003622:Dapsone
DAPSONE; DERMATITIS MEDICAMENTOSA; DRUG HYPERSENSITIVITY; DRUG RESISTANCE, MICROBIAL; LEPROSY; NIGERIA; SULFATHIAZOLES; SULFONAMIDES; SULFONES; TOXICOLOGIC REPORT